KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Long-Term Investments: 2010-2015

Historic Long-Term Investments for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $47.8 million.

  • Biocryst Pharmaceuticals' Long-Term Investments rose 15723.51% to $47.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $47.8 million, marking a year-over-year increase of 15723.51%. This contributed to the annual value of $41.1 million for FY2014, which is 1492.41% up from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' Long-Term Investments is $47.8 million, which was up 32.52% from $36.1 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' Long-Term Investments' 5-year high stood at $47.8 million during Q3 2015, with a 5-year trough of $302,000 in Q3 2014.
  • Moreover, its 3-year median value for Long-Term Investments was $2.7 million (2014), whereas its average is $19.2 million.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Long-Term Investments plummeted by 92.52% in 2012 and then soared by 15,723.51% in 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Long-Term Investments (Quarterly) stood at $15.4 million in 2011, then plummeted by 92.52% to $1.2 million in 2012, then surged by 124.33% to $2.6 million in 2013, then spiked by 1,492.41% to $41.1 million in 2014, then spiked by 15,723.51% to $47.8 million in 2015.
  • Its last three reported values are $47.8 million in Q3 2015, $36.1 million for Q2 2015, and $41.1 million during Q1 2015.